// App-Quantinova.ai

586 : Prognosis and correlation with Ca19.9 of circulating tumor cells (CTCs) in locally advanced and metastatic pancreatic cancer.

Researchers

Presenter

  • Andrs J. Muoz Martn

Principal Investigators

  • Laura Ortega Morn

  • Natalia Gutirrez Alonso

  • Diego Megias

  • Ana Lopez-Alfonso

  • Maria del Monte Milln

  • Rebeca Bernat

  • Roco Martn Lozano

  • Roberto Jimnez Rodrguez

  • Irene Gonzalez Caraballo

  • Luca Villarejo Lpez

  • Tatiana Massarrah

  • Gabriela Torres Prez-Solero

  • Aitana Calvo Ferrndiz

  • Montserrat Blanco-Codesido

  • Pilar Garcia-Alfonso

  • Miguel Martin

Medical Centers

  • Centro Nacional de Investigaciones Oncologicas, Madrid, Spain

  • Hospital Universitario Infanta Sofia, Madrid, Spain

  • Instituto de investigacion sanitaria gregorio maranon, Madrid, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

  • Oncology (ONC)

Disease

  • Metastatic pancreatic adenocarcinoma

Biomarkers

  • Carcinoembryonic antigen

  • Circulating tumor cells

  • Epidermal growth factor receptor

  • Epithelial Cell Adhesion Molecule

  • Solute Carrier Family 22 Member 3

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Observational

  • Prospective

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved